ARO-ANG 3 Injection

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)NCT05217667Arrowhead PharmaceuticalsPhase 2Terminated2023-05-02Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.